Targeting glycogen synthase kinase-3β for Alzheimer's disease: recent advances and future Prospects

Z Cheng, T Han, J Yao, K Wang, X Dong, F Yu… - European Journal of …, 2024 - Elsevier
Senile plaques induced by β-amyloid (Aβ) abnormal aggregation and neurofibrillary tangles
(NFT) caused by tau hyperphosphorylation are important pathological manifestations of …

Tanacetum species: Bridging empirical knowledge, phytochemistry, nutritional value, health benefits and clinical evidence

S Khatib, M Sobeh, C Faraloni… - Frontiers in …, 2023 - frontiersin.org
Introduction: The Tanacetum genus consists of 160 accepted flowering species thriving
throughout temperate regions, mainly in the Mediterranean Basin, Northern America, and …

A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease

C Pathak, UD Kabra - Bioorganic Chemistry, 2024 - Elsevier
Alzheimer's disease (AD) is the most common form of dementia affecting specifically older
population. AD is an irreversible neurodegenerative CNS disorder associated with complex …

Targeting microglia in neuroinflammation: H3 receptor antagonists as a novel therapeutic approach for Alzheimer's disease, Parkinson's disease, and autism spectrum …

SD Thomas, S Abdalla, N Eissa, A Akour, NK Jha… - Pharmaceuticals, 2024 - mdpi.com
Histamine performs dual roles as an immune regulator and a neurotransmitter in the
mammalian brain. The histaminergic system plays a vital role in the regulation of …

Evidence of disturbed insulin signaling in animal models of Alzheimer's disease

SS Alves, G Servilha-Menezes, L Rossi… - Neuroscience & …, 2023 - Elsevier
Since glucose reuptake by neurons is mostly independent of insulin, it has been an
intriguing question whether insulin has or not any roles in the brain. Consequently, the …

Understanding the journey of biopolymeric nanoformulations for oral drug delivery: Conventional to advanced treatment approaches

A Sharma, N Jangra, D Dheer, SK Jha, G Gupta… - European Polymer …, 2024 - Elsevier
The oral route of drug administration offers a convenient, cost-efficient, and non-invasive
means of administering medications. Nevertheless, as newly developed active …

A multi-target directed ligands strategy for the treatment of Alzheimer's disease: Dimethyl fumarate plus Tranilast modified Dithiocarbate as AChE inhibitor and Nrf2 …

J Guo, M Cheng, P Liu, D Cao, J Luo, Y Wan… - European Journal of …, 2022 - Elsevier
Alzheimer's disease (AD) possessed intricate pathogenesis. Currently, multi-targeted drugs
were considered to have the potential to against AD by simultaneously triggering molecules …

Multi-target QSAR modeling for the identification of novel inhibitors against Alzheimer's disease

V Kumar, A Saha, K Roy - Chemometrics and Intelligent Laboratory …, 2023 - Elsevier
Alzheimer's disease (AD) is an age-related neurodegenerative disorder, which is the most
common cause of dementia in elderly individuals. It is characterized by selective neuronal …

A review of the recent advances in Alzheimer's disease research and the utilization of network biology approaches for prioritizing diagnostics and therapeutics

R Hajjo, DA Sabbah, OH Abusara, AQ Al Bawab - Diagnostics, 2022 - mdpi.com
Alzheimer's disease (AD) is a polygenic multifactorial neurodegenerative disease that, after
decades of research and development, is still without a cure. There are some symptomatic …

Polypharmacology: promises and new drugs in 2022

P Ryszkiewicz, B Malinowska, E Schlicker - Pharmacological Reports, 2023 - Springer
Polypharmacology is an emerging strategy of design, synthesis, and clinical implementation
of pharmaceutical agents that act on multiple targets simultaneously. It should not be mixed …